Results 51 to 60 of about 157 (68)

Rainfall Data Analysis in Kerian River Basin Using HYFRAN-PLUS Model, Malaysia

Nor Faiza Abd Rahman, Yannick Mondelly, Vin Cent Tai, Munira Mohammad, Mohamad Shakri Mohmad Shariff, Khairi Khalid, Ee Li Siew   +6 more
openaire   +1 more source

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
Michael P Manns, J G McHutchison, Stuart C Gordon   +2 more
exaly  

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Mathias J Rummel, Norbert Niederle, Manfred Welslau   +2 more
exaly  

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2016
Li Zhang, Shaodong Hong, Peijian Peng
exaly  

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, Junki Mizusawa, N Okano   +2 more
exaly  

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Edward F McKone, Damian G Downey, Steven M Rowe   +2 more
exaly  

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of Oncology, 2011
Daisuke Aoki, Noriyuki Katsumata, I Konishi   +2 more
exaly  

Anxiety, defence and the elevated plus-maze

Neuroscience and Biobehavioral Reviews, 1997
R J Rodgers
exaly  

Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Journal of Clinical Microbiology, 2020
Jacob Bigio, Catherine A Hogan, Madhukar Pai   +2 more
exaly  

CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDE

Lancet, The, 1978
James C Wade, James J Lipsky, Jerrold Ellner   +2 more
exaly